
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Null Results in Brief |
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Requests for reprints: Kathryn H. Schmitz, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, MN 55454-1015. Phone: 612-625-8056; Fax: 612-624-0315. E-mail: schmitz{at}epi.umn.edu
| Introduction |
|---|
|
|
|---|
Animal models have suggested that insulin and insulin resistance may play roles in the etiology of pancreatic cancer (3, 4) and epidemiologic studies have shown an association between diabetes mellitus and increased risk of pancreatic cancer (5-7). Obesity, measured by body mass index (BMI) and waist-to-hip ratio (WHR), and physical activity can play roles in both insulin resistance and type II diabetes (8, 9).
Two recent prospective studies have examined pancreatic cancer incidence in relation to obesity and physical activity: Michaud et al. reported that individuals with a high BMI or low level of moderate physical activity were at an increased risk of pancreatic cancer (10), whereas Lee et al. reported that BMI and physical activity were not associated with pancreatic cancer risk (11). The Iowa Women's Health Study was used to analyze the association of obesity and physical activity with pancreatic cancer risk in older women.
| Materials and Methods |
|---|
|
|
|---|
Vital status was obtained through follow-up questionnaires in 1987, 1989, 1992, and 1997 and through the National Death Index. New pancreatic cancers (International Classification of Diseases for Oncology Second Edition code C25) were ascertained through the Iowa Cancer Registry, which is part of the national Surveillance, Epidemiology, End Results program. Subjects with a history of cancer other than nonmelanoma skin cancer at baseline were excluded (n = 3830). Pancreatic cancer cases determined to be islet cell carcinomas (n = 1), neuorendocrine carcinomas (n = 1), and leiomyosarcomas (n = 2) were also excluded. After these exclusions, 38,002 participants at risk, including 209 who developed pancreatic cancer through December 31, 2001, were included in this analysis. A sensitivity analysis was done to exclude participants diagnosed with pancreatic cancer before January 1, 1988 (n = 14). Results did not differ for the sensitivity analysis and therefore these cases of pancreatic cancer were included.
Methods of collection for physical activity, BMI at age 18, 30, 40, 50, and at baseline, and WHR, have been published elsewhere (12-14). Measures of baseline weight, height, and waist and hip circumferences were generally accurate and reliable (14). Participants were asked three questions about whether they participated in leisure time exercise and, if so, the frequency of moderate and heavy activities. The latter two questions were combined to create a three-level activity score.
Baseline characteristics were compared among participants who developed pancreatic cancer and those who did not using Pearson's
2 test or the t test. Age-adjusted and multivariate-adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) were computed using proportional hazards regression. Besides study variables mentioned previously, potential confounders that showed an association with both pancreatic cancer and the study variables (P < 0.10) were included in the multivariate models. These confounders included age, smoking status, and multivitamin use. All statistical analyses were done using SAS 8 software (15).
| Results |
|---|
|
|
|---|
|
30 kg/m2 at baseline had a HR of 1.14 (95% CI, 0.81-1.62) compared with a BMI < 25 kg/m2. Women in the highest tertile of WHR had a HR of 1.12 (95% CI, 0.81-1.55) compared with the lowest WHR tertile. Multivariate-adjusted pancreatic cancer incidence also was not associated with obesity based on self-recalled weights at age 18, 30, or 50, although obesity at age 40 unexpectedly carried a pancreatic cancer HR of 1.72 (95% CI, 1.12-2.63; results not shown).
|
| Discussion |
|---|
|
|
|---|
1.5. Limitations of our study were a short physical activity instrument, although one that does relate to CHD mortality (12), and single measures of exposure. Recent epidemiologic research has been inconclusive regarding the associations of physical activity and obesity with pancreatic cancer. Of seven studies on physical activity and pancreatic cancer, four reported no association (11, 16-18) and three reported an inverse association (10, 19, 20). Since 2000, six studies of obesity and pancreatic cancer incidence reported no association (11, 16, 17, 19, 21, 22), whereas six others reported a positive association (7, 10, 20, 23-25).
There is a plausible biological pathway through which physical inactivity and obesity could lead to pancreatic cancer. Obesity and physical inactivity are well-established risk factors for insulin resistance and type II diabetes (8, 9). Insulin resistance has been shown to induce islet cell proliferation and turnover, which in turn promotes pancreatic carcinogenesis (3, 26).
The next step for research in this area may be to pool data across several cohort studies that have addressed this hypothesis to increase power. Nevertheless, in this cohort, there was no evidence that obesity or physical inactivity play a role in pancreatic cancer etiology.
| Footnotes |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1/17/05; accepted 3/14/05.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Z. Stolzenberg-Solomon, K. Adams, M. Leitzmann, C. Schairer, D. S. Michaud, A. Hollenbeck, A. Schatzkin, and D. T. Silverman Adiposity, Physical Activity, and Pancreatic Cancer in the National Institutes of Health-AARP Diet and Health Cohort Am. J. Epidemiol., March 1, 2008; 167(5): 586 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Berrington de Gonzalez, E. A. Spencer, H. B. Bueno-de-Mesquita, A. Roddam, R. Stolzenberg-Solomon, J. Halkjaer, A. Tjonneland, K. Overvad, F. Clavel-Chapelon, M.-C. Boutron-Ruault, et al. Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 879 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Michaud and C. S. Fuchs Obesity and Pancreatic Cancer: Overall Evidence and Latency Period Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2678 - 2679. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |